Scientists explore factors that most affect our immune system

Feb 28 2018

Why do we respond differently to infections or vaccines? Why are some people allergic to pollen? These are still unanswered questions in biological and medical science. The Milieu Intérieur Laboratory of Excellence coordinated at the Institut Pasteur by CNRS research director, Dr. Lluis Quintana-Murci, has recently described immune variation on a large scale within the French population. To achieve this, the consortium studied an expansive collection of biological specimens from 1,000 French volunteers aged 20 to 69. This article provides an account of their work.

For many years, immunology, the branch of biology that examines our immune system, focused on dissecting the molecular mechanisms that control our physiological response to infections based on the assumption that this response does not differ among individuals. However, this premise has been challenged by recent studies suggesting that we are not all equally equipped to deal with pathogens. Our age, sex, infection history, and genetics can affect our immune system and make us more prone to disease. The task of identifying these factors that regulate our immune system has become the main challenge facing precision medicine, a proposed medical model aimed at offering patient treatments tailored to individual needs.

Some thirty scientists from several research centers thus joined forces to form the Milieu intérieur Laboratory of Excellence (or LabEx) coordinated at the Institut Pasteur by CNRS research director, Dr. Lluis Quintana-Murci with funding from the Investissements d'Avenir [Investing in the Future] program, with a view to describing immune variation on a large scale within the French population. This consortium gathered an expansive collection of biological specimens from 1,000 healthy donors (500 French men and 500 French women aged 20 to 69) recruited in Rennes. "The subjects' blood, DNA, vaccination and medical history, and intestinal and nasal bacteria were collected, measured, and examined for this large-scale study", explains Lluis Quintana-Murci. The first results from analysis of the entire cohort were recently published in PNAS on December 27, 2017 and in Nature Immunology on February 23, 2018.

Immune variation and differences in terms of sex and age

Using an ex vivo system, the researchers measured changes in immune gene expression in blood samples from the 1,000 donors when exposed to various viruses, bacteria, and fungi. At the same time, "we determined the molecular characteristics of the white blood cells, or leukocytes, in the donors' blood with an unprecedented level of precision", the CNRS researcher and study author Etienne Patin tells us. The two studies confirm that immune variation among individuals is largely due to differences in sex and age. "However, smoking and asymptomatic cytomegalovirus infection, which affects 35% of the population, also have a major impact on our blood cell composition. This may explain why smokers and people infected by this virus can be more prone to infection."

Genetic variations and risk of disease

The researchers' next task was to determine whether our genetics contribute to immune response variation among individuals. Surprisingly, "we identified hundreds of genetic variations which change the expression of molecules that play a key role in immune responses", reports Lluis Quintana-Murci "some of which are associated with a higher risk of developing diseases such as pollen allergy, lupus erythematosus, and type 1 diabetes." These results shed new light on the potential causes of these illnesses, which remain unclear.

The Milieu Intérieur Laboratory of Excellence (or Milieu intérieur LabEx) will now seek to determine whether our intestinal and nasal flora and epigenetics (temporary changes in our DNA) also contribute to immune variation. On a more general level, the extensive biobank developed for the purpose of this consortium will help identify disease risk factors, paving the way to precision medicine for infectious and autoimmune diseases.